Drug Profile
ARCT 032
Alternative Names: ARCT-032; ARTC032; LUNAR CF - Arcturus Theraepeutics; LUNAR-CF; mRNA CFTR therapeutic - Arcturus TherapeuticsLatest Information Update: 26 Feb 2024
Price :
$50
*
At a glance
- Originator Arcturus Therapeutics
- Developer Arcturus Therapeutics; Cystic Fibrosis Foundation Therapeutics
- Class Antifibrotics; RNA
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Cystic fibrosis